To: Francis Collins, MD, PhD, Director, National Institutes of Health
"The Endocrine Society appreciates the opportunity to respond to the Request for Information inviting feedback on the NIH-Wide Strategic Plan for COVID-19 Research. Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization dedicated to research on hormones and the clinical treatment of patients with endocrine diseases. Our members include leading experts on endocrine-related comorbidities for COVID-19, as well as the use of hormone-based therapies such as glucocorticoids, testosterone, and triiodothyronine. We welcome the Strategic Plan for COVID-19 Research and support NIH’s approach to continually updated the Plan to reflect new challenges presented by COVID-19. In our comments, we identify research priorities that NIH should include in future iterations of the Strategic Plan."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.